+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Drug Discovery Informatics - Global Market Trajectory & Analytics

  • ID: 4804178
  • Report
  • May 2020
  • Region: Global
  • 175 pages
  • Global Industry Analysts, Inc
1 of 2
Amid the COVID-19 crisis and the looming economic recession, the Drug Discovery Informatics market worldwide will grow by a projected US$2.1 Billion, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 11.5%. Sequencing & Target Data Analysis, one of the segments analyzed and sized in this study, is forecast to grow at over 13.4% and reach a market size of US$1.2 Billion by the end of the analysis period. An unusual period in history, the coronavirus pandemic has unleashed a series of unprecedented events affecting every industry. The Sequencing & Target Data Analysis market will be reset to a new normal which going forward in a post COVID-19 era will be continuously redefined and redesigned. Staying on top of trends and accurate analysis is paramount now more than ever to manage uncertainty, change and continuously adapt to new and evolving market conditions.

As part of the new emerging geographic scenario, the United States is forecast to readjust to a 11.5% CAGR. Within Europe, the region worst hit by the pandemic, Germany will add over US$79.6 Million to the region's size over the next 7 to 8 years. In addition, over US$83.9 Million worth of projected demand in the region will come from Rest of the European markets. In Japan, the Sequencing & Target Data Analysis segment will reach a market size of US$72.4 Million by the close of the analysis period. Blamed for the pandemic, significant political and economic challenges confront China. Amid the growing push for decoupling and economic distancing, the changing relationship between China and the rest of the world will influence competition and opportunities in the Drug Discovery Informatics market. Against this backdrop and the changing geopolitical, business and consumer sentiments, the world’s second largest economy will grow at 9.7% over the next couple of years and add approximately US$268.4 Million in terms of addressable market opportunity. Continuous monitoring for emerging signs of a possible new world order post-COVID-19 crisis is a must for aspiring businesses and their astute leaders seeking to find success in the now changing Drug Discovery Informatics market landscape. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others:

Certara USA, Inc, Charles River Laboratories International, Inc, Collaborative Drug Discovery, Inc, Dassault Systemes, GVK Biosciences Pvt, Ltd, IBM Corporation, Infosys Ltd, Jubilant Life Sciences Ltd, Novo Informatics Pvt, Ltd, Openeye Scientific Software, PerkinElmer, Inc, Schrodinger LLC, Selvita SA, Thermo Fisher Scientific, Inc.

The global analysis and forecast periods covered within the report are 2020-2027 (Current & Future Analysis) and 2012-2019 (Historic Review). Research estimates are provided for 2020, while research projections cover the period 2021-2027.
Note: Product cover images may vary from those shown
2 of 2
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Drug Discovery Informatics: A Prelude
Global Competitor Market Shares
Drug Discovery Informatics Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
Robust Drug Discovery Investments in Response to Growing Global Disease Burden Provides the Foundation for Growth in the Market
Growing Global Disease Burden Intensifies the R&D Urgency for New & Potent Drugs: Global Disease Burden (In Million DALYs (Disability-Adjusted Life Years)) for the Years 2015, 2017 & 2019
Rising Drug Development Spending Acts as the Chief Catalyst for the Adoption of Drug Discovery Informatics: Global Pharmaceutical R&D Spending (In US$ Billion) for the Years 2017, 2019, 2022 and 2024
Migration to Data Driven Drug Development Provides the Cornerstone for Growth in the Market
Growing Focus on Optimizing Hit to Lead (H2L) Processes in Early Stage Drug Discovery to Benefit Growth of Drug Discovery Informatics/Chemoinformatics
Growing Use of In-Silico Methods in Drug Development Bodes Well for the Use of Informatics
The Rise of Nanoinformatics as the New Era of Research in Nanomedicine Marks the Beginning of Use of Informatics in Nanomedicine
Exploding Commercial Opportunity for Nanomedicine Bodes Well for the Growth of Nanoinformatics: Global Nanomedicine Market (In US$ Billion) for the Years 2017, 2019, 2022 and 2024
Cloud Computing Emerges to Play a Key Role in Bioinformatics
Cost Benefits Over In-House Informatics Helps Expand the Commercial Visibility of Outsourced Informatics
Continuously Evolving CRO Industry Highlights the Growing Importance & Value of Pharma R&D Outsourcing: Global Contract Research Organization (CRO) Market (In US$ Billion) for the Years 2017, 2019, 2022 and 2024
Robust Adoption of Bioinformatics Services Highlights the Growing Dominance of Informatics Outsourcing Over Traditional In-House Informatics: Global Bioinformatics Services Market (In US$ Billion) by Service Type for the Years 2017, 2019, 2022 and 2024
Competitive Challenges Faced by the Pharma Industry & the Ensuing Need for Decision Support Tools & Collaborative Discovery Opens the Flood Gates of Opportunity for Drug Discovery Informatics
Rising Global Healthcare Spending Spurs Government Focus On Cost Containment Driving Pharma Companies to Cut Drug Prices by Reducing Research Costs: Global Healthcare Spending (In US$ Trillion) by Government, Private & Consumer Out-of-Pocket for the Years 2017, 2019, 2022 and 2025
Productivity Gains, Acceleration of Speed & Success of Drug Discovery Research Drive Adoption of Drug Discovery Informatics
Move Towards Value-Based Care & the Resulting Emergence of the Era of Precision Medicine Catalyzes the Commercial Value of Drug Discovery Informatics
Robust Outlook for Precision Medicine Strengthens the Business Case for Drug Discovery Informatics: Global Market for Precision Medicine (In US$ Billion) for the Years 2017, 2019, 2022 and 2024

4. GLOBAL MARKET PERSPECTIVE
TABLE 1: Drug Discovery Informatics Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027
TABLE 2: Drug Discovery Informatics Market Share Shift across Key Geographies Worldwide: 2020 VS 2027
TABLE 3: Sequencing & Target Data Analysis (Function) World Market by Region/Country in US$ Thousand: 2020 to 2027
TABLE 4: Sequencing & Target Data Analysis (Function) Market Share Breakdown of Worldwide Sales by Region/Country: 2020 VS 2027
TABLE 5: Docking (Function) Potential Growth Markets Worldwide in US$ Thousand: 2020 to 2027
TABLE 6: Docking (Function) Market Sales Breakdown by Region/Country in Percentage: 2020 VS 2027
TABLE 7: Molecular Modelling (Function) Geographic Market Spread Worldwide in US$ Thousand: 2020 to 2027
TABLE 8: Molecular Modelling (Function) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027
TABLE 9: Library Preparation (Function) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2020 to 2027
TABLE 10: Library Preparation (Function) Market Share Breakdown by Region/Country: 2020 VS 2027
TABLE 11: Other Functions (Function) World Market by Region/Country in US$ Thousand: 2020 to 2027
TABLE 12: Other Functions (Function) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027
TABLE 13: Software (Solution) World Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020 to 2027
TABLE 14: Software (Solution) Market Percentage Share Distribution by Region/Country: 2020 VS 2027
TABLE 15: Services (Solution) Market Opportunity Analysis Worldwide in US$ Thousand by Region/Country: 2020 to 2027
TABLE 16: Services (Solution) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027
TABLE 17: Pharmaceutical & Biotechnology Companies (End-Use) Worldwide Sales in US$ Thousand by Region/Country: 2020-2027
TABLE 18: Pharmaceutical & Biotechnology Companies (End-Use) Market Share Shift across Key Geographies: 2020 VS 2027
TABLE 19: Contract Research Organizations (CROS) (End-Use) Global Market Estimates & Forecasts in US$ Thousand by Region/Country: 2020-2027
TABLE 20: Contract Research Organizations (CROS) (End-Use) Market Share Breakdown by Region/Country: 2020 VS 2027
TABLE 21: Other End-Uses (End-Use) Demand Potential Worldwide in US$ Thousand by Region/Country: 2020-2027
TABLE 22: Other End-Uses (End-Use) Share Breakdown Review by Region/Country: 2020 VS 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Drug Discovery Informatics Market Share (in %) by Company: 2019 & 2025
Dwindling Government Funding Support for Healthcare R&D, A Major Challenge for Growth in the Country
Market Analytics
TABLE 23: United States Drug Discovery Informatics Market Estimates and Projections in US$ Thousand by Function: 2020 to 2027
TABLE 24: United States Drug Discovery Informatics Market Share Breakdown by Function: 2020 VS 2027
TABLE 25: United States Drug Discovery Informatics Market Estimates and Projections in US$ Thousand by Solution: 2020 to 2027
TABLE 26: United States Drug Discovery Informatics Market Share Breakdown by Solution: 2020 VS 2027
TABLE 27: United States Drug Discovery Informatics Latent Demand Forecasts in US$ Thousand by End-Use: 2020 to 2027
TABLE 28: Drug Discovery Informatics Market Share Breakdown in the United States by End-Use: 2020 VS 2027
CANADA
TABLE 29: Canadian Drug Discovery Informatics Market Estimates and Forecasts in US$ Thousand by Function: 2020 to 2027
TABLE 30: Drug Discovery Informatics Market in Canada: Percentage Share Breakdown of Sales by Function for 2020 and 2027
TABLE 31: Canadian Drug Discovery Informatics Market Estimates and Forecasts in US$ Thousand by Solution: 2020 to 2027
TABLE 32: Drug Discovery Informatics Market in Canada: Percentage Share Breakdown of Sales by Solution for 2020 and 2027
TABLE 33: Canadian Drug Discovery Informatics Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2020 to 2027
TABLE 34: Canadian Drug Discovery Informatics Market Share Analysis by End-Use: 2020 VS 2027
JAPAN
TABLE 35: Japanese Market for Drug Discovery Informatics: Annual Sales Estimates and Projections in US$ Thousand by Function for the Period 2020-2027
TABLE 36: Japanese Drug Discovery Informatics Market Share Analysis by Function: 2020 VS 2027
TABLE 37: Japanese Market for Drug Discovery Informatics: Annual Sales Estimates and Projections in US$ Thousand by Solution for the Period 2020-2027
TABLE 38: Japanese Drug Discovery Informatics Market Share Analysis by Solution: 2020 VS 2027
TABLE 39: Japanese Demand Estimates and Forecasts for Drug Discovery Informatics in US$ Thousand by End-Use: 2020 to 2027
TABLE 40: Drug Discovery Informatics Market Share Shift in Japan by End-Use: 2020 VS 2027
CHINA
TABLE 41: Chinese Drug Discovery Informatics Market Growth Prospects in US$ Thousand by Function for the Period 2020-2027
TABLE 42: Chinese Drug Discovery Informatics Market by Function: Percentage Breakdown of Sales for 2020 and 2027
TABLE 43: Chinese Drug Discovery Informatics Market Growth Prospects in US$ Thousand by Solution for the Period 2020-2027
TABLE 44: Chinese Drug Discovery Informatics Market by Solution: Percentage Breakdown of Sales for 2020 and 2027
TABLE 45: Chinese Demand for Drug Discovery Informatics in US$ Thousand by End-Use: 2020 to 2027
TABLE 46: Chinese Drug Discovery Informatics Market Share Breakdown by End-Use: 2020 VS 2027
EUROPE
Market Facts & Figures
European Drug Discovery Informatics Market: Competitor Market Share Scenario (in %) for 2019 & 2025
Market Analytics
TABLE 47: European Drug Discovery Informatics Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025
TABLE 48: European Drug Discovery Informatics Market Share Shift by Region/Country: 2020 VS 2027
TABLE 49: European Drug Discovery Informatics Market Estimates and Forecasts in US$ Thousand by Function: 2020-2027
TABLE 50: European Drug Discovery Informatics Market Share Breakdown by Function: 2020 VS 2027
TABLE 51: European Drug Discovery Informatics Market Estimates and Forecasts in US$ Thousand by Solution: 2020-2027
TABLE 52: European Drug Discovery Informatics Market Share Breakdown by Solution: 2020 VS 2027
TABLE 53: European Drug Discovery Informatics Addressable Market Opportunity in US$ Thousand by End-Use: 2020-2027
TABLE 54: European Drug Discovery Informatics Market Share Analysis by End-Use: 2020 VS 2027
FRANCE
TABLE 55: Drug Discovery Informatics Market in France by Function: Estimates and Projections in US$ Thousand for the Period 2020-2027
TABLE 56: French Drug Discovery Informatics Market Share Analysis by Function: 2020 VS 2027
TABLE 57: Drug Discovery Informatics Market in France by Solution: Estimates and Projections in US$ Thousand for the Period 2020-2027
TABLE 58: French Drug Discovery Informatics Market Share Analysis by Solution: 2020 VS 2027
TABLE 59: Drug Discovery Informatics Quantitative Demand Analysis in France in US$ Thousand by End-Use: 2020-2027
TABLE 60: French Drug Discovery Informatics Market Share Analysis: A 7-Year Perspective by End-Use for 2020 and 2027
GERMANY
TABLE 61: Drug Discovery Informatics Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Function for the Period 2020-2027
TABLE 62: German Drug Discovery Informatics Market Share Breakdown by Function: 2020 VS 2027
TABLE 63: Drug Discovery Informatics Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Solution for the Period 2020-2027
TABLE 64: German Drug Discovery Informatics Market Share Breakdown by Solution: 2020 VS 2027
TABLE 65: Drug Discovery Informatics Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2020-2027
TABLE 66: Drug Discovery Informatics Market Share Distribution in Germany by End-Use: 2020 VS 2027
ITALY
TABLE 67: Italian Drug Discovery Informatics Market Growth Prospects in US$ Thousand by Function for the Period 2020-2027
TABLE 68: Italian Drug Discovery Informatics Market by Function: Percentage Breakdown of Sales for 2020 and 2027
TABLE 69: Italian Drug Discovery Informatics Market Growth Prospects in US$ Thousand by Solution for the Period 2020-2027
TABLE 70: Italian Drug Discovery Informatics Market by Solution: Percentage Breakdown of Sales for 2020 and 2027
TABLE 71: Italian Demand for Drug Discovery Informatics in US$ Thousand by End-Use: 2020 to 2027
TABLE 72: Italian Drug Discovery Informatics Market Share Breakdown by End-Use: 2020 VS 2027
UNITED KINGDOM
TABLE 73: United Kingdom Market for Drug Discovery Informatics: Annual Sales Estimates and Projections in US$ Thousand by Function for the Period 2020-2027
TABLE 74: United Kingdom Drug Discovery Informatics Market Share Analysis by Function: 2020 VS 2027
TABLE 75: United Kingdom Market for Drug Discovery Informatics: Annual Sales Estimates and Projections in US$ Thousand by Solution for the Period 2020-2027
TABLE 76: United Kingdom Drug Discovery Informatics Market Share Analysis by Solution: 2020 VS 2027
TABLE 77: United Kingdom Demand Estimates and Forecasts for Drug Discovery Informatics in US$ Thousand by End-Use: 2020 to 2027
TABLE 78: Drug Discovery Informatics Market Share Shift in the United Kingdom by End-Use: 2020 VS 2027
REST OF EUROPE
TABLE 79: Rest of Europe Drug Discovery Informatics Market Estimates and Forecasts in US$ Thousand by Function: 2020-2027
TABLE 80: Rest of Europe Drug Discovery Informatics Market Share Breakdown by Function: 2020 VS 2027
TABLE 81: Rest of Europe Drug Discovery Informatics Market Estimates and Forecasts in US$ Thousand by Solution: 2020-2027
TABLE 82: Rest of Europe Drug Discovery Informatics Market Share Breakdown by Solution: 2020 VS 2027
TABLE 83: Rest of Europe Drug Discovery Informatics Addressable Market Opportunity in US$ Thousand by End-Use: 2020-2027
TABLE 84: Rest of Europe Drug Discovery Informatics Market Share Analysis by End-Use: 2020 VS 2027
ASIA-PACIFIC
TABLE 85: Drug Discovery Informatics Market in Asia-Pacific by Function: Estimates and Projections in US$ Thousand for the Period 2020-2027
TABLE 86: Asia-Pacific Drug Discovery Informatics Market Share Analysis by Function: 2020 VS 2027
TABLE 87: Drug Discovery Informatics Market in Asia-Pacific by Solution: Estimates and Projections in US$ Thousand for the Period 2020-2027
TABLE 88: Asia-Pacific Drug Discovery Informatics Market Share Analysis by Solution: 2020 VS 2027
TABLE 89: Drug Discovery Informatics Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by End-Use: 2020-2027
TABLE 90: Asia-Pacific Drug Discovery Informatics Market Share Analysis: A 7-Year Perspective by End-Use for 2020 and 2027
REST OF WORLD
TABLE 91: Rest of World Drug Discovery Informatics Market Estimates and Forecasts in US$ Thousand by Function: 2020 to 2027
TABLE 92: Drug Discovery Informatics Market in Rest of World: Percentage Share Breakdown of Sales by Function for 2020 and 2027
TABLE 93: Rest of World Drug Discovery Informatics Market Estimates and Forecasts in US$ Thousand by Solution: 2020 to 2027
TABLE 94: Drug Discovery Informatics Market in Rest of World: Percentage Share Breakdown of Sales by Solution for 2020 and 2027
TABLE 95: Rest of World Drug Discovery Informatics Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2020 to 2027
TABLE 96: Rest of World Drug Discovery Informatics Market Share Analysis by End-Use: 2020 VS 2027

IV. COMPETITION
Total Companies Profiled: 41
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll